Learn about Acute Bacterial Bronchitis, also known as Bacterial Bronchitis or Acute Infectious Bronchitis. This page provides information on diagnosis, clinical documentation, and medical coding for healthcare professionals. Find details on symptoms, treatment, and management of Acute Bacterial Bronchitis for accurate and efficient clinical practice and documentation.
Also known as
Acute bronchitis
Inflammation of the bronchi, often due to infection.
Diseases of the respiratory system
Encompasses various respiratory conditions including infections and inflammations.
Chronic lower respiratory diseases
Long-term conditions affecting the lungs and airways, sometimes related to acute bronchitis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the bronchitis confirmed as acute and bacterial?
When to use each related code
| Description |
|---|
| Sudden bacterial lung infection in the airways. |
| Inflammation of the bronchi, often viral. |
| Long-term inflammation and mucus in bronchi. |
Coding acute bacterial bronchitis without specifying the causative organism can lead to rejected claims or lower reimbursement.
Misdiagnosing viral bronchitis as bacterial can lead to inappropriate antibiotic prescriptions and inaccurate coding.
Insufficient documentation of symptoms and diagnostic testing can lead to coding and billing errors, triggering audits.
Q: How to differentiate acute bacterial bronchitis from viral bronchitis in pediatric patients with persistent cough?
A: Differentiating acute bacterial bronchitis (ABB) from viral bronchitis in children with a persistent cough can be challenging due to overlapping symptoms. While both present with cough, ABB often involves a productive cough with purulent sputum, possibly accompanied by fever and elevated inflammatory markers like CRP and procalcitonin. Viral bronchitis typically presents with a dry or minimally productive cough alongside other viral symptoms like rhinorrhea or sore throat. However, these distinctions are not always clear-cut. Consider auscultating for focal crackles or wheezing which may suggest ABB, though these findings can be present in viral bronchitis as well. Chest X-rays are generally not recommended for uncomplicated bronchitis but may be considered in cases of severe illness or diagnostic uncertainty to exclude pneumonia. Explore how implementing a validated clinical prediction rule, such as the one developed by Harris et al. (2017), can aid in distinguishing ABB from viral bronchitis and guide antibiotic prescribing decisions in children. Learn more about the importance of judicious antibiotic use to minimize the risk of antibiotic resistance.
Q: What are the evidence-based antibiotic treatment recommendations for confirmed acute bacterial bronchitis in adults?
A: Antibiotic treatment for confirmed acute bacterial bronchitis (ABB) in adults should be guided by local resistance patterns and patient-specific factors. First-line therapy typically involves amoxicillin or doxycycline. For patients with penicillin allergies, macrolides like azithromycin or clarithromycin may be considered, though increasing macrolide resistance necessitates careful consideration. In cases of suspected or confirmed atypical pathogens like Mycoplasma pneumoniae or Chlamydia pneumoniae, a respiratory fluoroquinolone (e.g., levofloxacin or moxifloxacin) or a tetracycline (e.g., doxycycline) may be appropriate. Treatment duration typically ranges from 5 to 7 days for most cases of ABB, but longer courses may be necessary for specific pathogens or complicated presentations. Consider implementing guidelines from reputable sources like the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) for managing adult ABB. Explore how antibiotic stewardship programs can help optimize antibiotic prescribing practices and reduce the emergence of antibiotic resistance.
Patient presents with symptoms consistent with acute bacterial bronchitis, also known as bacterial bronchitis or acute infectious bronchitis. The patient reports a productive cough with thick mucus, chest discomfort, and shortness of breath. Symptoms onset was approximately one week ago, initially presenting as a common cold with rhinorrhea and mild cough. The cough has progressively worsened, becoming productive with purulent sputum. Patient denies fever, chills, or night sweats. Lung auscultation reveals diffuse wheezing and rhonchi. No signs of consolidation or pleural effusion are noted. Differential diagnoses considered include viral bronchitis, pneumonia, and asthma exacerbation. Given the presentation of purulent sputum and the progression of symptoms, acute bacterial bronchitis is the most likely diagnosis. Treatment plan includes a course of antibiotics, such as amoxicillin or doxycycline, along with bronchodilators for symptomatic relief of wheezing and cough. Patient education provided on proper antibiotic use, hydration, and cough hygiene. Follow-up scheduled in one week to assess response to treatment. ICD-10 code J20.9, acute bronchitis, unspecified, is assigned. Medical billing codes will reflect the evaluation and management service provided, along with codes for prescribed medications and any diagnostic tests performed.